KS

Karamjeet Singh

Active Director Director DIN 10751700
DIN 10751700 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Karamjeet Singh

Data last updated:

Karamjeet Singh is a Director at Alpex Pharma Private Limited (since 2024). The company operates in Pharma. Alpex Pharma Private Limited reported revenue of ₹26.00 Cr (FY 2025).

DIN 10751700
Primary Designation Director
Industry Pharma
First Appointment 24 Aug 2024
Oldest Company Age 4 yrs
Largest company Alpex Pharma Private Limited · ₹26.00 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alpex Pharma Private Limited U24299HR2022PTC102687
Director24 Aug 20242022₹26.00 Cr (FY 2025)Active

Board colleagues of Karamjeet Singh

Directorship timeline

Open interactive timeline →
Alpex Pharma Private Limited
Premium access

Shareholding and investment profile for Karamjeet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karamjeet Singh

Karamjeet Singh currently holds 1 directorship: Alpex Pharma Private Limited (Director, since 24 Aug 2024, revenue ₹26.00 Cr (FY 2025)).

Karamjeet Singh was first appointed on 24 Aug 2024 as Director at Alpex Pharma Private Limited.

The current boards of Karamjeet Singh's companies include Harchand Singh (Alpex Pharma Private Limited), Sanjay Mittal (Alpex Pharma Private Limited), Shubham Mittal (Alpex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available